Oligozoospermia, Asthenozoospermia, Teratozoospermia, Fertility
Conditions
Keywords
Randomized controlled trial, Spermatozoa, Sperm, Male Infertility, Walnuts, Nutrition, Male Reproduction
Brief summary
The investigators are testing the hypothesis that two ounces of whole-shelled walnuts/day added to the diet of men seeking care for infertility will beneficially affect sperm parameters and fertility. The investigators will compare the walnut intervention to the commonly suggested recommendation of adding an OTC multivitamin supplement to the diet.
Detailed description
Purpose: The investigators are testing the hypothesis that two ounces of whole-shelled walnuts/day added to the diet of men with oligo- astheno- or teratospermia will beneficially affect sperm parameters. The investigators found in a previous study (Robbins et al. 2012, Biology of Reproduction 87(4):101, 1-8.) that walnuts added to a Western diet improved sperm parameters in healthy, young men of unknown fertility and the most improvement occurred in participants with poor sperm parameters at baseline. The investigators now test the walnut dietary intervention in a fertility clinic population known to have poor sperm parameters. The investigators will compare the walnut intervention to the usual care suggestion of adding an OTC multivitamin supplement to the diet. Neither walnuts nor the OTC multivitamin have been tested for efficacy in this fertility clinic population previously. Methods: A randomized, parallel two-group, dietary intervention trial with single-blind masking of outcome assessors will be conducted with up to 140 men who present for fertility work-up with semen parameters below the 25th centile for count, and 10th centile for motility and/or morphology according to the WHO 5th Edition, Laboratory Manual for the Processing and Examining of Human Semen, 2010. Repeated measures at baseline and 12 weeks include: semen analyses (primary outcome), blood fatty acid/ nutrient profiles (secondary outcomes); IPAQ physical activity questionnaire and IIEF index of erectile function (potential modifiers or confounders). Dietary intake will be assessed throughout using 24-hour ASA dietary recall x 5 and fertility assessed by questionnaire at one year post enrollment.
Interventions
DIETARY_SUPPLEMENTWalnuts
DIETARY_SUPPLEMENTOTC multivitamin
Sponsors
University of California, Los Angeles
Cedars-Sinai Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
MALE
Age
21 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 21 years or older * Sperm concentration \< or = to 41 million per ml * Sperm motility \< or = to 40% * Normal sperm morphology forms \< or = to 5.5% * Patients of Howard H. Kim, MD seen at the Male Reproductive Medicine and Microsurgery Clinic, Cedars-Sinai Medical Center, Los Angeles, California * Have eaten walnuts throughout life without adverse reaction
Exclusion criteria
* Allergy to walnuts or tree nuts * Food allergy * Known genetic cause of infertility * Known anatomical cause of infertility * History of seizure disorder
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Sperm count | 12 weeks | Change from baseline to three months in sperm count |
| Sperm motility | 12 weeks | Change from baseline to 12 weeks in sperm motility |
| Sperm morphology | 12 weeks | Change from baseline to 12 weeks in sperm morphology |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fertility | 12 months | Fertilization of ova through natural conception or assisted reproductive technology |
| Blood fatty acid and nutrient profile | 12 weeks | Change from baseline to 12 weeks in blood fatty acid profile and nutrients |
| Sperm aneuploidy | 12 weeks | Change from baseline to 12 weeks in sperm aneuploidy |
| Sperm DNA strand breakage | 12 weeks | Change from baseline to 12 weeks in sperm DNA integrity |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORHoward H Kim, MD
Cedars-Sinai Medical Center, Los Angeles, CA
PRINCIPAL_INVESTIGATORWendie A Robbins, RN, PhD
University of California, Los Angeles
Outcome results
None listed